Faculty and Staff News
Direct from the Dean: Hess outlines multiple actions focused on diversity, equity and inclusiveness
Editor’s note: The following is an excerpt from a message sent by IU School of Medicine Dean Jay L. Hess, MD, PhD, MHSA, to the school community on Monday, June 1.
Against a backdrop of over 100,000 Americans dying of COVID-19—many from underserved populations—the killings of Ahmaud Arbery in Georgia, George Floyd in Minnesota and other heartbreaking events highlight the depth of the racial inequalities and injustices that persist throughout our society. These events are reprehensible and need to be addressed from multiple fronts. Throughout the country—including here in Indianapolis—people are gathering to express their sadness and frustration at the lack of action. This has prompted many discussions at the school about what we are doing, and can do, to confront these problems and make a difference.
As Dean, I am committed to making the school a place where all individuals in the medical school community, at all nine campuses, feel valued, respected and encouraged. I know from firsthand experience, discussions and surveys that at times we fall short of our goals. We have work to do. What we don’t need now are platitudes; we need tangible steps to improve the climate in our community, the sense of security and belonging, beginning with all the members of our community of color. Those steps must be taken by all of us—by people of all colors—to effect true change.
I also recognize that it is difficult when it appears we are not acting on individual cases, when in fact we are, but must keep our actions confidential as required by law.
Based on a number of discussions, we plan to implement a set of actions beginning in the 2020-2021 academic year, which include:
- Reviewing existing data on the state of racial diversity and inclusiveness at IU School of Medicine, implementing a climate survey and openly sharing and discussing the results.
- Establishing a series of town hall meetings to review data and solicit additional input on actions to improve diversity, equity and inclusiveness.
- Increasing the office hours of the Deans of Student Affairs and Diversity Affairs to provide more opportunities for school leadership to hear what our community has to say about our climate and how it can be improved.
- Implementing regular training for faculty and learners on the topics of unconscious bias, microaggressions, cultural humility and professionalism.
- Conducting a comprehensive review of the medical school curriculum to address the potential presence of biases and microaggressions.
- Enhancing the curriculum to better address eliminating health disparities.
- Integrating diversity, equity and inclusion into the competency assessment system across every level of training.
- Improving information, resources and transparency around expectations of professionalism and potential consequences of Honor Code violations, which includes acts of racism and bigotry.
Read the full message for more details, including a request for feedback, information about reporting mistreatment and lapses in professionalism, and the independent Ombuds office at IU School of Medicine for confidential sharing of concerns and advice.
Lowden to lead information technology for IU
Rob Lowden, executive associate dean and chief information officer for IU School of Medicine, has been named vice president for information technology and chief information officer for Indiana University. Lowden’s appointment, which will take effect on August 3, was part of senior leadership changes announced earlier this week by IU President Michael A. McRobbie.
“As IU School of Medicine’s first senior leader solely dedicated to information technology, Rob has done an outstanding job during the past 18 months in envisioning and working to implement a comprehensive IT strategy for our school,” said Dean Jay L. Hess, MD, PhD, MHSA, executive vice president for university clinical affairs. “With his experience and expertise, he is the ideal person to lead information technology at the university level, and we look forward to working with him in his new executive leadership role with IU.”
Plans related to the CIO position at IU School of Medicine are under consideration. For more on Lowden’s appointment and other IU leadership changes announced this week, visit News at IU.
IU School of Medicine makes significant progress restarting research
For an unprecedented period of time, many IU School of Medicine research labs sat idle, waiting along with faculty and staff, for a break in the COVID-19 pandemic. The break, along with the ability to restart research (which hadn’t already been deemed essential or able to be conducted remotely), came in late May with the IU Restart Committee Recommendations Report, prepared by a committee chaired by IU School of Medicine Dean Jay L. Hess, MD, PhD, MHSA, and followed by the guidelines for the Resumption of Research at Indiana University.
Consistent with Indiana Governor Eric Holcomb’s plan to reopen Indiana in phases, IU School of Medicine took a similar phased approach to restarting research, beginning with the Indianapolis-based research service cores, which provide much of the needed equipment, technology and services required to support research, such as genomics, proteomics and much more.
Before restarting, a restart checklist was provided that asked the core directors to create plans to ensure their safety and the safety of their lab personnel from COVID-19, including a 30-day supply of PPE, the ability to physically distance, lab rotation schedules and many more necessary considerations. Once approved by the dean’s office, directors were asked to provide their staff with five days’ notice prior to restarting.
A similar checklist and plans are required for restarting bench and clinical research as part of phases two and three of the phased research restart plan.
As of Monday, June 8, 19 cores have restarted their research based on approved restart plans. Eight cores have been invited to restart as part of phase two, which will also include 152 bench research labs with approved restart plans, scheduled to restart as early as Monday, June 15.
Forty-four clinical research plans have been approved to restart according to a phased approach and have the added responsibility of also ensuring the facilities in which clinical research is being conducted are prepared and outfitted for research to resume.
“We are well on our way to having a significant portion of our research labs restarted by the end of June,” said Carmel Egan, PhD, associate dean for research affairs. “July 6 is the last planned date for the final phase of clinical research to restart. I want to thank every department chair, center director, principal investigator and person whose role touches research in any way for their engagement, dedication and commitment to this serious and important restart. Your work has been a service to the entire IU research community.”
The Office of Research Affairs has created several tools to support a successful restart, including bench and clinical research restart checklists, sample restart plans, a frequently asked questions document and more. With questions related to the research restart, email firstname.lastname@example.org.
Hiller named associate dean and director for IU School of Medicine–Bloomington
Katherine M. Hiller, MD, MPH, has been appointed associate dean and director of IU School of Medicine–Bloomington, effective July 1.
Hiller comes to IU School of Medicine from University of Arizona College of Medicine-Tucson where she served for more than a decade as director for undergraduate emergency medicine for the Department of Emergency Medicine. Her experience also includes graduate medical education and faculty development, having initiated mentorship programs for junior faculty, including women faculty, and running the Medical Education/Simulation residency track for the past five years. Hiller also served on numerous committees, most recently representing the Department of Emergency Medicine and College of Medicine as a senator for the University of Arizona Faculty Senate.
On the national level, Hiller is immediate past president of the Clerkship Directors in Emergency Medicine Academy of the Society for Academic Emergency Medicine, and is a founding member of the Emergency Medicine Advanced Clinical Exam task force with the National Board of Medical Examiners, a member of the AAMC Standardized Video Interview Working Group, and an item writer for the American Board of Emergency Medicine. Additionally, she has extensively published high-quality medical education research, presented at numerous conferences, served as a medical expert for local media, and acted as a principal investigator or collaborator on several grant-funded projects.
In an email to colleagues announcing Hiller’s appointment, Paul M. Wallach, MD, executive associate dean for educational affairs and institutional improvement, wrote: “Under Dr. Hiller’s leadership, our Bloomington campus will continue advancing its cutting-edge biomedical research, while educating learners on multiple pathways for graduate and undergraduate degree programs.”
Hiller earned a bachelor of science degree in chemistry and biochemistry from the University of Arizona-Tucson, and a medical degree from The Ohio State University College of Medicine. She completed a transitional internship at Kern Medical Center in Bakersfield, California, before heading to Denver Health Medical Center for her residency in emergency medicine, where she was junior chief resident. She holds a certificate from the Arizona Clinical Research Training Program and earned a Master of Public Health (MPH) degree from the University of Arizona.
Gutmann appointed neurology chair
Laurie Gutmann, MD, has been named chair for the IU School of Medicine Department of Neurology, effective October 1. In addition to holding the title of chair, Gutmann will be co-director of the Neuroscience Institute, an umbrella entity designed to facilitate collaboration among neuroscience disciplines at IU School of Medicine and IU Health.
Gutmann currently serves as vice chair of clinical research and director of the Neurology Office of Clinical Trials for the Department of Neurology at the University of Iowa, as well as associate director of clinical research for the Iowa Neuroscience Institute.
Her leadership on the national level includes serving eight years as a director for the American Board of Psychiatry and Neurology (ABPN), including three years as chair of the Neurology Council, and serving on the Neurology Review Committee of the Accreditation Council for Graduate Medical Education (ACGME), chairing the committee for the last three years. Working with a diverse group of colleagues, Gutmann helped revise the Neurology Program requirements for the ACGME, and she has led or participated in several initiatives for the American Academy of Neurology encompassing workforce development, women’s leadership and educational programs.
Previously, Gutmann served as a program officer for the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health and was faculty at West Virginia University and at the University of Iowa. Her work helped build a multidisciplinary stroke research program at West Virginia and the multidisciplinary Myotonic Dystrophy Clinic and funded myotonic dystrophy research program at Iowa. She has been co-principal investigator on an NINDS site infrastructure grant for early clinical trials in rare neurological disorders (NeuroNEXT). She also developed the Neurology Office of Clinical Trials at Iowa, which is now self-sustaining and supports over 60 clinical trials. Additionally, Gutmann and three collaborators developed an NINDS-funded Clinical Trials Methodology Course that trains up to 30 new clinical trial investigators a year.
In an email message announcing Gutmann’s appointment, IU School of Medicine Dean Jay L. Hess, MD, PhD, MHSA, wrote: “Dr. Gutmann is arriving at a time when the Department of Neurology is in an exciting research growth phase and is now 21st in NIH ranking with research studies on Alzheimer’s disease and related disorders, neuromuscular disorders, epilepsy, movement disorders, neuropsychology, pediatric neurology and stroke. She will add momentum to these efforts, bringing a vision for enhancing collaboration across neuro research areas, including clinical, translational and basic science research, as well as collaboration across departments to enhance clinical care, while maintaining the department’s strong educational focus.”
Gutmann earned a bachelor’s degree with honors in biology from Oberlin College (Ohio) and a medical degree from West Virginia University Medical School. She completed a transitional year residency at Hamot Medical Center in Erie, Pa., and her neurology residency at University of Virginia, where she continued her training as a Neuromuscular Diseases/EMG Fellow.
School receives $7 million education grant to help eliminate health disparities
IU School of Medicine was recently awarded a $7 million grant from the Health Resources & Services Administration (HRSA) to help the school educate medical students to better care for underserved populations. As the state and nation continue to deal with the devastating effects of the COVID-19 pandemic, as well as addressing racial inequities captivating the national consciousness, this grant is aimed at helping IU School of Medicine lead the way in eliminating health care deficits.
The grant will fund a project called Primary Care Reaffirmation for Indiana Medical Education (PRIME). The goal of the program is to provide doctors with the tools needed to offer better care to medically underserved and vulnerable communities, both in primary and specialty care.
PRIME will enhance the IU School of Medicine curriculum by focusing on social determinants of health, primary care skills and health systems science. The curriculum will incorporate telehealth, ultrasound, student-driven community improvement projects and scholarly concentrations. Experiential training opportunities also will be expanded throughout the state, particularly in underserved Indiana communities. This project reaches beyond medical school and will be coupled with primary care residency expansion around the state.
The HRSA grant will award $1.75 million annually for four years with a goal of giving medical students at IU School of Medicine deeper curricular and experiential exposure for providing primary care to underserved areas and populations across the state.
For more on the grant, visit the Newsroom.
May research awards total over $7.4 million
May research awards Investi gator Sponsor Type Project Title Begin Date End Date Awarded Dollars Amelia K Linnemann Grace M. Showalter Trust New Evaluating the Role of NRF2 in Beta Cell Mitophagy Regulation 7/1/2020 6/30/2021 $75,000 Andy Qigui Yu University Of Pittsburgh New Molecular Mechanisms of HBV cccDNA Formation 11/1/2019 2/28/2021 $20,500 Bo Zhao Royal National Institute For Deaf People New CLIC5 functions in hearing and deafness 4/1/2020 3/31/2023 $199,404 Bradley N. Bohnstedt University Of Texas Health Science Center Houston New SEGA - SEdation versus General Anesthesia for Endovascular Therapy in Acute Ischemic Stroke - a Randomized Comparative Effectiveness Trial. 4/27/2020 6/30/2021 $48,800 Brandalyn C Riedel Alzheimer Association New Contributions of Mitochondrial Genetics to Risk for Alzheimer's Disease 5/1/2020 4/30/2022 $118,889 Carmella Evans-Molina Riley Children's Foundation Renewal (not prev commit ted) Luke Bracken Wiese Fund for Juvenile Diabetes at Riley Hospital for Children 1/1/2020 12/31/2020 $100,000 David L Boone National Institute Of Diabetes, Digestive & Kidney New A role for the stomach in protection from colitis 5/1/2020 1/31/2021 $521,231 David M Haas Arizona State University New Identifying Metabolic Differences During Pregnancies in Mothers of Children Later Diagnosed with ASD 11/1/2019 10/31/2020 $12,740 Don Jay Selzer Foundation For Surgical Fellowships New Bariatric/MIS surgical fellowship grant 8/1/2021 7/31/2022 $20,000 Eric Orman Duke University Renewal (not prev commit ted) PAL-LIVER (¿Palliative Care in the Treatment of End Stage Liver Disease: A Randomized Controlled Trial¿) (Year 3) 1/1/2020 12/31/2020 $150,000 Erica A. Eugster Riley Children's Foundation Renewal (not prev commit ted) Diabetes Education Endowment Fund 7/1/2019 6/30/2020 $120,755 Gary D. Hutchins Radiological Society Of North America New Novel Molecular Imaging Approach for Whole Body Tumor Perfusion Assessment 5/1/2020 7/20/2021 $3,000 Hyun Cheol Roh Grace M. Showalter Trust New Role of NFIL3 in Immune Regulation of Beige Adipocyte Transdiffer entiation 7/1/2020 6/30/2021 $50,000 Jeffrey Allen Kline National Heart, Lung And Blood Institute New BEdside Exclusion of Pulmonary Embolism in children without Radiation (BEEPER) 4/15/2020 3/31/2021 $1,937,790 Jeni Prosperi Grace M. Showalter Trust New Paclitaxel re-sensitization by CDK1 inhibition 7/1/2020 6/30/2021 $75,000 Jonathan Dick Washington University New An Adaptive Strategy for Preventing and Treating Lapses of Retention in Adult HIV Care II (ADAPT-R II) 9/12/2019 8/31/2020 $8,869 Kathleen T Unroe Grace M. Showalter Trust New Showalter Scholar - Kathleen Unroe 7/1/2020 6/30/2021 $25,000 Kenneth E. White National Institute Arthritis Musculo skeletal Skin New FGF23 induction in phosphate-responsive single cells 4/1/2020 3/31/2021 $174,350 Kenneth Lim National Institute Of Diabetes, Digestive & Kidney New Dissecting the role of soluble a-Klotho in cardiovascular aging 5/1/2020 4/30/2021 $155,678 Kenneth P Nephew Duke University Renewal (not prev commit ted) Novel Genomic Mechanism for Ligand-Dependent Transcription by Androgen Receptor 3/1/2020 2/28/2021 $14,493 Li Chen Grace M. Showalter Trust New Computational methods for integrative analysis of noncoding variants and multi-omics data with applications to Alzheimer's disease 7/1/2020 6/30/2021 $75,000 Lucian Craig Warth Dartmouth-hitchcock Medical Center New Comparative Effectiveness of Pulmonary Embolism Prevention after Hip and Knee Replacement (PEPPER): Balancing Safety and Effectiveness 7/1/2019 2/29/2020 $31,145 Matthias A Clauss Tulane University New Exploratory Research on HIV Contribution to Heart and Lung Comorbidities 4/1/2020 2/28/2021 $80,754 Michael A. Weiss National Institute Of Diabetes, Digestive & Kidney New Molecular Endocrinology and Principles of Diabetes Therapeutics: Application to Ultra-Stable Insulin Analogs 7/1/2020 6/30/2021 $647,357 Naga P. Chalasani National Institute Of Diabetes, Digestive & Kidney New Ancillary Studies of NAFLD and NASH in HIV infected Adults 3/21/2020 1/31/2021 $1,703,139 Oluwafisa yo O Adebiyi Johns Hopkins University New HOPE in Action: A clinical trial of HIV-to-HIV deceased donor kidney transplantation 8/1/2019 7/31/2020 $17,000 Rachel Adria Katzen ellenbogen National Cancer Institute Renewal (not prev commit ted) High-risk HPV E6: dysregulation of immortalization, growth, and differentiation through protein partnerships in HPV-associated cancers 6/1/2020 5/31/2021 $318,779 Randall T Loder Riley Children's Foundation Renewal (not prev commit ted) George J. Garceau Professor in Pediatric Orthopaedic Surgery 7/1/2018 6/30/2019 $24,220 Randall T Loder Riley Children's Foundation Renewal (not prev commit ted) George and Peggy Rapp Pediatric Orthopaedic Fund 7/1/2018 6/30/2019 $24,598 Randall T Loder Riley Children's Foundation Renewal (not prev commit ted) George and Peggy Rapp Pediatric Orthopaedic Fund 7/1/2019 6/30/2020 $24,546 Randall T Loder Riley Children's Foundation Renewal (not prev commit ted) George J. Garceau Professor in Pediatric Orthopaedic Surgery 7/1/2019 6/30/2020 $24,107 Rebecca S Aguirre Endocrine Fellows Foundation New The Role of Beta Cell Exosomal Proinsulin in the Pathogenesis of Type 1 Diabetes 5/5/2020 5/4/2021 $5,000 Robert V. Considine Indiana Biosciences Research Institute New Annie Pineros Alvarez Research Support 10/1/2019 2/28/2020 $30,704 Roberto F Machado Cleveland Clinic Foundation Renewal (not prev commit ted) Mechanisms of metabolic dysregulation in pulmonary hypertension 3/1/2020 2/28/2021 $118,692 Sandeep Batra Children's Hospital Of Philadelphia New COG ADVL1823 ¿ Bayer Consumer Care AG 4/6/2020 4/5/2025 $3,000 Scott T Aoki Grace M. Showalter Trust New The molecular mechanisms of tissue-specific gene regulatory networks in health and starvation 7/1/2020 6/30/2021 $75,000 Steven S Welc Muscular Dystrophy Association New The Role of Klotho in Fibro/ Adipogenic Progenitor Cell Fate in Dystrophic Muscle 10/1/2019 1/31/2022 $141,550 Steven S Welc Grace M. Showalter Trust New Functions of TRPC6 and calcium signaling in regulating muscle mesenchymal cell differentiation and pathological muscle fibrosis 7/1/2020 6/30/2021 $75,000 Sumegha Mitra Grace M. Showalter Trust New Proteasome Inhibition is a Novel Approach to Target High-Grade Serous Ovarian Cancer 7/1/2020 6/30/2021 $75,000 Tatiana M Foroud University Of Pennsylvania Renewal (not prev commit ted) Alzheimer's Disease Genetics Consortium 4/15/2020 3/31/2021 $53,505 Tatiana M Foroud Michael J Fox Foundation For Parkinsons Research New Global Parkinson's Genetics Program (GP2) - 2020 Working Group Lead 4/1/2020 3/31/2021 $25,000 Zhihong (Joe) Yang Grace M. Showalter Trust New Novel roles of ¿-hydroxylation enzymes in the pathogenesis of alcoholic liver disease 7/1/2020 6/30/2021 $75,000
Testing treatments for COVID-19
Samir Gupta, MD, is joining researchers all over the world to study the effects of remdesivir on patients with COVID-19. Gupta, professor of medicine in the Division of Infectious Diseases, has been leading two separate studies regarding the use of remdesivir.
The first study involves giving remdesivir to hospitalized patients who did not need extra oxygen at two different durations, for five or 10 days. The second study involves giving severely ill patients (who need extra oxygen or were on a ventilator) remdesivir for five or 10 days. The goal of both studies is to determine whether five or 10 days would be sufficient to help the patient recover, as well as reducing side effects.
For more on the studies, read the Research Updates blog post.
Researchers grow hairy skin from human stem cells
Building on years of groundbreaking discoveries in stem cell research, scientists from IU School of Medicine and Harvard Medical School have determined how to grow hairy skin using human stem cells—developing one of the most complex skin models in the world.
The study, published in Nature on Wednesday, June 3, shows that skin generated from pluripotent stem cells can be successfully grafted on a nude mouse to grow human skin and hair follicles. That discovery could lead to future studies in skin reconstruction, disease modeling and treatment.
“This is the first study to show that human hair can be grown completely from stem cells in a dish, which has been a goal of the skin biology community for decades,” said Karl Koehler, PhD, assistant professor of otolaryngology—head and neck surgery at Harvard Medical School and Boston Children’s Hospital.
The team of researchers was led by Koehler, who’s also an adjunct assistant professor of otolaryngology—head and neck surgery at IU School of Medicine, and Jiyoon Lee, PhD, a research associate in Koehler’s lab.
The group’s findings originate from several years of stem cell research within the Department of Otolaryngology—Head and Neck Surgery at IU School of Medicine. In 2013, scientists created inner ear tissue from mouse embryonic stem cells using a three-dimensional cell culture method. In 2017, they developed a method to grow inner ear tissue from human stem cells, and in 2018, the researchers grew hairy skin in a dish using mouse stem cells, a scientific first.
Visit the Newsroom for more on the research.
Faculty and Staff News
Tu named interim chair of biostatistics
Tu, who joined the IU School of Medicine faculty in 1999, most recently served as the department’s vice chair for research and played an integral role in launching the Department of Biostatistics in 2011.
A statistical methodologist with a broad research portfolio in both clinical trials and observational studies, Tu has developed innovative analytical methods and has published in top statistical journals, particularly in the area of hypertension. As an NIH-funded lead investigator, many of his methods have had strong impacts on clinical investigations. Tu’s appointment as interim chair will ensure continuity for the Department of Biostatistics, which provides data analytical operations supporting much of the clinical research conducted at Indiana University.
Become a faculty career mentor
Choosing a medical specialty is one of the most significant decisions a medical student will make. Faculty career mentors provide medical students with information and resources to effectively make career decisions that lead them toward a successful residency match.
Medical Student Education has developed a comprehensive career mentoring program that is integrated throughout the curriculum at all nine campuses. Learn more about the important role of faculty career mentors and how you can participate.
Take Healthy IU’s hydration challenge to beat the summer heat
The seven-day Hydration Challenge involves daily emails that give participants a hydration tip for the day. The Day 1 email provides a Healthy IU hydration tracker to use throughout the challenge, which can be completed any time until Friday, July 31. Full-time IU employees and their spouses who are on the IU-sponsored medical plan will receive a Healthy IU water bottle after completing the challenge. Bottles will be delivered via campus mail once employees are able to return to their campuses.
Check out News at IU for more details.
Looking ahead to fall: Webpage offers HR info for IU staff
The announcement that on-campus instruction will resume at all IU campuses in the fall has raised questions for IU employees. The IU Human Resources webpage, Working Through COVID-19, offers information about policies and procedures regarding safety, instruction and remote working. Note that IU School of Medicine policies may differ slightly or be more specific. Check the school’s COVID-19 Resources page or contact your supervisor with questions.
Find out about Kelley’s online “mini MBA”; Zoom info session is July 15
The Kelley Graduate Certificate in Medical Management provides business knowledge and many benefits of an MBA with a lower financial investment and shorter time commitment. Participants can complete the graduate certificate in just 12 months, while working, either online or in person. The program is available at no tuition cost to IU School of Medicine employees. Learn more and sign up for the next Zoom information session on Wednesday, July 15.
Judges needed for virtual IMPRS summer research symposium
The IU Medical Student Program for Research and Scholarship (IMPRS) is hosting a virtual summer research poster symposium on Thursday, July 30. The annual event showcases research and scholarly projects completed by rising second-year medical students from all nine IU School of Medicine campuses. Event organizers need educators and researchers to serve as judges. Time commitment includes reviewing the judging guidelines and approximately 10 posters/recordings submitted by the students, as well as filling out a brief scorecard for each poster. Interested? Complete the brief RedCap form or send an email to IMPRS@iupui.edu.
New graduate courses focus on drug discovery and development
The IU School of Medicine Division of Clinical Pharmacology is offering graduate courses that take learners on a journey through the entire drug discovery and development process. Taught by industry veterans and scientific experts, the courses are Discovering Novel Treatments (CLPH-D 501) and Developing Clinically Approved Medicines (CLPH-D 502). Classes for the fall 2020 semester are from noon-1:30 pm on Tuesday and Thursday in the Medical Science Building. (Note: The 501 course must be completed first.)
Learn more by attending the virtual open house from 3-4 pm, Monday, June 29. Faculty will be online to explain the courses in detail and answer questions.
Updated visitor restrictions at IU Health take effect on Monday
Beginning Monday, June 15, IU Health is revising its visitor restrictions. The guidelines will allow for one visitor per patient, per day in inpatient areas across the system. Visitors must be 18 or older and will be screened and provided with a mask, which must be worn at all times while inside the facility. Special visitor restrictions will remain for COVID-19 positive patients, with the same exceptions in place (end of life, special patient circumstances where benefit outweighs risk).
“Becker’s Hospital Review” highlights IU Health’s commitment to team members
“Becker's Hospital Review” recently included an article about IU Health's commitment to no layoffs or salary cuts for its 34,000 employees despite the financial hit caused by the COVID-19 pandemic. Read the interview with IU Health Senior Vice President and CFO Jenni Alvey.
IU Health to disable Outlook auto forwarding feature on July 1
The auto forwarding feature in IU Health Outlook email will be removed on Wednesday, July 1. The only exceptions are for emails forwarded from IU Health email accounts to IU School of Medicine accounts, and for physician practice groups that have a large presence at IU Health (ACI, OrthoIndy, etc.), which IU Health has worked with to verify their security. Those will not be affected by this change.
Auto forwarding is used by many physicians working for multiple systems to limit the number of inboxes they have to check throughout the day. However, using the auto forwarding feature to forward to personal email addresses puts patient and team member information at risk. IU Health safeguards its patient and team member information and continually monitors activity to prevent any malicious intent. Unfortunately, non-IU Health email accounts cannot be trusted because there is no record that the same safety precautions are followed.
Questions? Contact the IU Health Service Desk at 317-962-2828.